TTTrudy R. Turner

Trudy R. Turner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Trudy R. Turner has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Judith Masters and Fabien Génin: An unwavering union in strepsirrhine evolution

    by Sébastien Couette, Curswan A. Andrews, Luca Pozzi, Trudy Turner, Massimiliano Delpero

    This preamble honors the late evolutionary primatologists Judith Masters and Fabien Génin, synthesizing their profound impact on strepsirrhine anatomy, systematics, and biogeography. Over four decades, Masters applied Hugh Paterson's Recognition Concept of species alongside comprehensive craniodental morphometrics and phylogenetics to reframe the evolutionary trees of nocturnal African galagos, culminating in the formal description of the dwarf galago genus Paragalago . Génin complemented this systematic framework by linking sensory ecology with comparative physiology, providing groundbreaking evidence of energetic plasticity—such as facultative heterothermy and torpor—in Malagasy mouse lemurs. Together, their collaborative research challenged major primatological paradigms by refuting the “primitive” status of cheirogaleids and critiquing standard socio‐ecological models in favor of species‐recognition frameworks driven by sensory drive. Furthermore, their interdisciplinary work proposed an alternative view of vertebrate colonization of Madagascar. Beyond their empirical contributions, they established the African Primate Initiative for Ecology and Speciation (APIES) and the Primate Ecology and Genetics Group (PEGG), leaving a lasting legacy of regional capacity‐building and postgraduate mentorship that reshaped southern African primatology.

  • With Thanks

    by Trudy R. Turner

  • Evidence of selection in the uncoupling protein 1 gene region suggests local adaptation to solar irradiance in savannah monkeys ( Chlorocebus spp.)

    by Christian M. Gagnon, Hannes Svardal, Anna J. Jasinska, Jennifer Danzy Cramer, Nelson B. Freimer, J. Paul Grobler, Trudy R. Turner, Christopher A. Schmitt

    In the last 300 thousand years, the genus Chlorocebus expanded from equatorial Africa into the southernmost latitudes of the continent, where colder climate was a probable driver of natural selection. We investigated population-level genetic variation in the mitochondrial uncoupling protein 1 ( UCP1 ) gene region—implicated in non-shivering thermogenesis (NST)—in 73 wild savannah monkeys from three taxa representing this southern expansion ( Chlorocebus pygerythrus hilgerti, Chlorocebus cynosuros and Chlorocebus pygerythrus pygerythrus ) ranging from Kenya to South Africa. We found 17 single nucleotide polymorphisms with extended haplotype homozygosity consistent with positive selective sweeps, 10 of which show no significant linkage disequilibrium with each other. Phylogenetic generalized least-squares modelling with ecological covariates suggest that most derived allele frequencies are significantly associated with solar irradiance and winter precipitation, rather than overall low temperatures. This selection and association with irradiance is demonstrated by a relatively isolated population in the southern coastal belt of South Africa. We suggest that sunbathing behaviours common to savannah monkeys, in combination with the strength of solar irradiance, may mediate adaptations to thermal stress via NST among savannah monkeys. The variants we discovered all lie in non-coding regions, some with previously documented regulatory functions, calling for further validation and research.


  • Open Access

    Evidence of selection in UCP1 gene region suggests local adaptation to irradiance rather than cold temperatures in savanna monkeys ( Chlorocebus spp.)

    by Christian M. Gagnon, Hannes Svardal, Anna J. Jasinska, Jennifer Danzy Cramer, Nelson B. Freimer, J. Paul Grobler, Trudy R. Turner, Christopher A. Schmitt

    The genus Chlorocebus is widely distributed throughout sub-Saharan Africa, and in the last 300 thousand years expanded from equatorial Africa into the southernmost latitudes of the continent. In these new environments, colder climate was a likely driver of natural selection. We investigated population-level genetic variation in the mitochondrial uncoupling protein 1 ( UCP1 ) gene region – implicated in non-shivering thermogenesis within brown/beige adipocytes – in 73 wild savanna monkeys from three taxa representing this southern expansion ( C. pygerythrus hilgerti, C. cynosuros, C. p. pygerythrus ) ranging from Kenya to South Africa. We found 17 SNPs with extended haplotype homozygosity consistent with positive selective sweeps, 10 of which show no significant LD with each other. Phylogenetic generalized least squares modeling with ecological covariates suggest that most derived allele frequencies are significantly associated with solar irradiance and winter precipitation, rather than overall low temperatures. This selection and association with irradiance appears to be driven by a population isolate in the southern coastal belt of South Africa. We suggest that sunbathing behaviors common to savanna monkeys, in combination with strength of solar irradiance, may mediate adaptations to thermal stress via non-shivering thermogenesis among savanna monkeys. The variants we discovered all lie in non-coding regions, some with previously documented regulatory functions, calling for further validation and research.


  • Open Access

    ACE2 and TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies

    by Christopher A. Schmitt, Christina M. Bergey, Anna J. Jasinska, Vasily Ramensky, Felicity Burt, Hannes Svardal, Matthew J. Jorgensen, Nelson B. Freimer, J. Paul Grobler, Trudy R. Turner

    The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has devastated health infrastructure around the world. Both ACE2 (an entry receptor) and TMPRSS2 (used by the virus for spike protein priming) are key proteins to SARS-CoV-2 cell entry, enabling progression to COVID-19 in humans. Comparative genomic research into critical ACE2 binding sites, associated with the spike receptor binding domain, has suggested that African and Asian primates may also be susceptible to disease from SARS-CoV-2 infection. Savanna monkeys (Chlorocebus spp.) are a widespread non-human primate with well-established potential as a bi-directional zoonotic/anthroponotic agent due to high levels of human interaction throughout their range in sub-Saharan Africa and the Caribbean. To characterize potential functional variation in savanna monkey ACE2 and TMPRSS2, we inspected recently published genomic data from 245 savanna monkeys, including 163 wild monkeys from Africa and the Caribbean and 82 captive monkeys from the Vervet Research Colony (VRC). We found several missense variants. One missense variant in ACE2 (X:14,077,550; Asp30Gly), common in Ch. sabaeus, causes a change in amino acid residue that has been inferred to reduce binding efficiency of SARS-CoV-2, suggesting potentially reduced susceptibility. The remaining populations appear as susceptible as humans, based on these criteria for receptor usage. All missense variants observed in wild Ch. sabaeus populations are also present in the VRC, along with two splice acceptor variants (at X:14,065,076) not observed in the wild sample that are potentially disruptive to ACE2 function. The presence of these variants in the VRC suggests a promising model for SARS-CoV-2 infection and vaccine and therapy development. In keeping with a One Health approach, characterizing actual susceptibility and potential for bi-directional zoonotic/anthroponotic transfer in savanna monkey populations may be an important consideration for controlling COVID-19 epidemics in communities with frequent human/non-human primate interactions that, in many cases, may have limited health infrastructure.


  • Open Access

    ACE2 and TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies

    by Christopher A. Schmitt, Christina M. Bergey, Anna J. Jasinska, Vasily Ramensky, Felicity Burt, Hannes Svardal, Matthew J. Jorgensen, Nelson B. Freimer, J. Paul Grobler, Trudy R. Turner

    The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has devastated health infrastructure around the world. Both ACE2 (an entry receptor) and TMPRSS2 (used by the virus for spike protein priming) are key proteins to SARS-CoV-2 cell entry, enabling progression to COVID-19 in humans. Comparative genomic research into critical ACE2 binding sites, associated with the spike receptor binding domain, has suggested that Old World primates may also be susceptible to disease from SARS-CoV-2 infection. Savanna monkeys (Chlorocebus spp.) are a widespread non-human primate with well-established potential as a bi-directional zoonotic/anthroponotic agent due to high levels of human interaction throughout their range in sub-Saharan Africa and the Caribbean. To characterize potential functional variation in savanna monkey ACE2 and TMPRSS2, we inspected recently published genomic data from 245 savanna monkeys, including 163 wild monkeys from Africa and the Caribbean and 82 captive monkeys from the Vervet Research Colony (VRC). We found several missense variants. One missense variant in ACE2 (X:14,077,550; Asp30Gly), common in Ch. sabaeus, causes a change in amino acid residue that has been inferred to reduce binding efficiency of SARS-CoV-2, suggesting potentially reduced susceptibility. The remaining populations appear as susceptible as humans, based on these criteria for receptor usage. All missense variants observed in wild Ch. sabaeus populations are also present in the VRC, along with two splice acceptor variants (at X:14,065,076) not observed in the wild sample that are potentially disruptive to ACE2 function. The presence of these variants in the VRC suggests a promising model for SARS-CoV-2 infection and vaccine and therapy development. In keeping with a One Health approach, characterizing actual susceptibility and potential for bi-directional zoonotic/anthroponotic transfer in savanna monkey populations may be an important consideration for controlling COVID-19 epidemics in communities with frequent human/non-human primate interactions that, in many cases, may have limited health infrastructure.


  • Editorial

    by Trudy R. Turner